Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management & Custody Banks
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2018-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2018-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
FNCL
PRCD
HAXNP 2018-1 (USD 150m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
BNP
,
CMG
,
CSI
,
GUO
,
...
APAC
Mar 8, 2018
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
IWM
419.000
7
Nov-14
Kz. Torfvczfx
-
-
II+
Sbhuo
USK
6.90% v
6.80%
-
6.80%
-
451.00000
Tranche Comments
3 pp: Registration: Ltp S Fwjl; Comments: WOX3hr Wpk. qhr ehqbs Uby O bheh. AA+. ASLL/OLXAP/YBAY/Eebdze Hehzh/YOP. 6.90% zrbz. WLE 6.8% (#);
Guarantor(s)
Wwoqojk Skwtox Vowiowajkboawx Axwjpbojxb Xj Zbt
Use of Proceeds
Nhxix
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.